Stay Connected With Us

trodelvy

MD News Daily- Gilead Sciences To Acquire Immunomedics for $21 Billion Dollar

GILEAD Sciences Inc Strengthens Its Cancer Portfolio Through Immunomedics Acquisition

Sep 13, 2020 PM EDT

Gilead gains access to Immunomedics's breast cancer treatment drug, Trodelvy through this billion-dollar acquisition.

Right Now

Healthy Living 5 Benefits of Visiting A Dentist Regularly

5 Benefits of Visiting A Dentist Regularly
Medicine Where Do Unused and Expired Medications Go?

Where Do Unused and Expired Medications Go?
Real Time Analytics